HealthyDirect · GrowthFit for a long SIP
360 ONE Multi Asset Allocation Fund
360 ONE Mutual FundHybrid Schemes - Multi Asset Allocation Fund1.2 years
The scheme seeks to provide the investors an opportunity to invest in an actively managed portfolio of multiple asset classes.
- NAV
- 11.7988
- 30 Oct 2026
- 1Y
- +7.8%
- Trailing CAGR
- AUM
- ₹520.76 Cr
- 30 Sept 2026
- Volatility
- Medium
- 12.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 1-year windows.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Fail
1.2 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.68% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -9.9%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Viral Mehta · 1.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 50.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 10%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+7.8%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+14.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-2.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +14.8%
- Calendar-day CAGR
- Excess 1Y
- +5.4%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -9.9%
- Worst peak-to-trough
- Current
- -7.4%
- Below last peak
- Current spell
- 67 days
- Days below latest peak
- Time below peak
- +86%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 13 days
- 18 recovered episodes
- Longest recovery
- 150 days
- Trough to prior peak
29 Jan 2026 – 20 Aug 2026
Trough 23 Mar 2026 · recovered in 150 days
-9.9%
24 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-7.6%
15 Oct 2025 – 1 Dec 2025
Trough 28 Oct 2025 · recovered in 34 days
-3.3%
21 Jan 2026 – 27 Jan 2026
Trough 22 Jan 2026 · recovered in 5 days
-1.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
40
Vs category
84
Consistency
100
Risk-adjusted
64
Drawdown
75
Mean
73
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 74 holdings · top 10 are 50.7%.
- Top 5
- 40.5%
- Top 10
- 50.7%
- Largest holding
- 18.6%
- Effective holdings
- 17.1
360 ONE Gold ETF-Growth
Unspecified
18.6%
ICICI Prudential Silver ETF - Growth
Unspecified
10.8%
Reverse Repo
Unspecified
5.9%
ICICI Prudential Gold Exchange Traded Fund IDCW
Unspecified
2.8%
CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY LIMITED SR 637 8.60 NCD 05MR29 FVRS1LAC
Financial
2.3%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
DSP Multi Asset Allocation Fund
DSP Mutual Fund
- 1Y
- +4.4%
- 3Y
- +17.1%
- Vol
- 8.9%
- Max DD
- -9.7%
- Sharpe
- 1.26
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Lower TER
- Higher trailing returns
WhiteOak Capital Multi Asset Allocation Fund
WhiteOak Capital Mutual Fund
- 1Y
- +6.0%
- 3Y
- +16.0%
- Vol
- 5.6%
- Max DD
- -6.1%
- Sharpe
- 1.57
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Lower TER
- Higher trailing returns
Mahindra Manulife Multi Asset Allocation Fund
Mahindra Manulife Mutual Fund
- 1Y
- +4.2%
- 3Y
- n/a
- Vol
- 9.0%
- Max DD
- -9.5%
- Sharpe
- 0.81
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Mirae Asset Multi Asset Allocation Fund
Mirae Asset Mutual Fund
- 1Y
- +4.1%
- 3Y
- n/a
- Vol
- 8.8%
- Max DD
- -9.1%
- Sharpe
- 0.68
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Shriram Multi Asset Allocation Fund
Shriram Mutual Fund
- 1Y
- +0.0%
- 3Y
- +10.1%
- Vol
- 11.9%
- Max DD
- -15.3%
- Sharpe
- 0.34
- 3Y win
- 0%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown